Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Genet Mol Res ; 13(1): 2248-58, 2014 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-24737473

RESUMO

Radioactive iodine-131 (131I) is used in the treatment and diagnosis of thyroid gland injuries. However, because it emits ionizing radiation, it causes harmful effects to cells. Given that beta-carotene (BC) has antioxidant and antigenotoxic properties, this study aimed to investigate its radioprotective and antimutagenic activity in relation to 131I at the dose that is used to treat hyperthyroidism using a test system of bone marrow cells from Wistar rats (Rattus norvegicus). The doses were 0.2 mL of 8 mg BC/mL corn oil and 25 µCi 131I per 100 g body weight, and they were given via gavage in acute and subchronic treatments. Treatment groups included simultaneous, pre-treatment, post-treatment, and continuous treatment types. In all antimutagenic acute treatments, BC had a significant antimutagenic/radioprotective activity in relation to 131I. In subchronic antimutagenic treatments, BC reduced the damage that was caused by the radioisotope; however, this reduction was not statistically significant because of the relatively low percentage of chromosomal abnormalities that were observed with only 131I compared to the acute treatment. These results demonstrate the radioprotective and antimutagenic activity of BC, indicating its use by the population, which inevitably is exposed to mutagenic agents, as a means of health protection.


Assuntos
Antimutagênicos/farmacologia , Radioisótopos do Iodo/efeitos adversos , Protetores contra Radiação/farmacologia , Compostos Radiofarmacêuticos/efeitos adversos , beta Caroteno/farmacologia , Animais , Antimutagênicos/administração & dosagem , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/efeitos da radiação , Aberrações Cromossômicas/efeitos dos fármacos , Aberrações Cromossômicas/efeitos da radiação , Feminino , Radioisótopos do Iodo/administração & dosagem , Masculino , Índice Mitótico , Protetores contra Radiação/administração & dosagem , Compostos Radiofarmacêuticos/administração & dosagem , Ratos , Fatores de Tempo , beta Caroteno/administração & dosagem
2.
Genet Mol Res ; 13(1): 578-89, 2014 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-24615023

RESUMO

Fluoxetine, commonly known as Prozac, is the first representative of the so-called new generation of antidepressants that promise efficacy, with few side effects, against deep depression, nervous bulimia, and anxiety. As there is a growing number of people suffering from anxiety and depression; consequently, the use of fluoxetine is also increasing. Verifying absence of drug effects such as cytotoxicity or mutagenicity is of great importance. Certain vitamins, such as vitamin A (retinol, retinoids) and vitamin C (ascorbic acid) protect and are extremely active against mutagens. We evaluated the cytotoxic and mutagenic activity of fluoxetine, with and without concomitant administration of vitamin A or C, in Allium cepa meristem cells and Wistar rat bone marrow cells. The A. cepa meristem cells showed fluoxetine cytotoxicity; concomitant treatment with vitamin A or C proved non-protective. Treatment of Wistar rats with fluoxetine intraperitoneally or via gavage did not affect cell division or cause clastogenic effects. Vitamin A and C did not affect the cytotoxicity or mutagenicity of fluoxetine in the rat cells.


Assuntos
Fluoxetina/administração & dosagem , Mutagênicos/administração & dosagem , Cebolas/efeitos dos fármacos , Animais , Ácido Ascórbico/administração & dosagem , Divisão Celular/efeitos dos fármacos , Combinação de Medicamentos , Fluoxetina/efeitos adversos , Humanos , Testes de Mutagenicidade , Mutagênicos/efeitos adversos , Cebolas/genética , Ratos , Vitamina A/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA